Rubicon Research Files Business Responsibility & Sustainability Report for FY25-26
Rubicon Research Ltd. has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report, which also forms part of the Integrated Annual Report for FY2025-26, is available on the company's website. It details the company's corporate information, business activities focused entirely on pharmaceutical formulations, and operational presence including 3 national plants and 7 international offices. Exports account for 98.44% of total turnover. The report also provides employee demographics and details on female representation on the Board and among Key Management Personnel.
Key Highlights
- Rubicon Research submitted its Business Responsibility and Sustainability Report for FY2025-26.
- The report is integrated into the company's Annual Report for the same fiscal year.
- Company's core business is 100% in pharmaceutical formulations and products.
- Exports contribute a significant 98.44% to the company's total turnover.
- Female representation stands at 25% on the Board and 50% among Key Management Personnel.
Price Impact
More from RUBICON